Delayed Treatment Acceleration in Patients with Rheumatoid Arthritis Who Have Inadequate Response to Initial Tumor Necrosis Factor Inhibitors: Data from the Corrona Registry.

Dimitrios A. Pappas, Robert A. Gerber, Heather J. Litman, David Gruben, Jamie Geier, Winnie Hua, Connie Chen, Youfu Li, Joel M. Kremer, John S. Andrews, J BourretPubMed 2018

Abstract

In this real-world analysis of data from the Corrona RA registry, a considerable proportion of patients with RA had an inadequate response to the initial TNF inhibitor therapy at 6 and 12 months. Many patients continued to have moderate or high disease activity, without accelerating treatment (eg, addition or increase in the dose of concurrent conventional synthetic DMARDs or a TNF inhibitor), contrary to treat-to-target principles, thus remaining at risk for accumulating joint damage and disability.
BibTeX
@inproceedings{pappas2018delayed,
  author = {Dimitrios A. Pappas and Robert A. Gerber and Heather J. Litman and David Gruben and Jamie Geier and Winnie Hua and Connie Chen and Youfu Li and Joel M. Kremer and John S. Andrews and J Bourret},
  title = {{Delayed Treatment Acceleration in Patients with Rheumatoid Arthritis Who Have Inadequate Response to Initial Tumor Necrosis Factor Inhibitors: Data from the Corrona Registry.}},
  booktitle = {PubMed},
  year = {2018},
}

Loading related content...

Figure